within the rapidly evolving subject of oncology research, check here precise and efficient mutation screening is essential for developing focused therapies. The KRAS solutions Platform plays a pivotal purpose in this landscape by supplying extensive solutions for KRAS mutation profiling and Evaluation. KRAS mutations, present in roughly 95% of RAS-